{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/68beeb540e15f0d455abc0b7/696d34ea4788cf9ec69b47bf?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Relapsed large cell lymphoma and bispecific","description":"<p>A blended AI podcast summary of <a href=\"https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.20129\" rel=\"noopener noreferrer\" target=\"_blank\">BSH guidelines on relapsed and refractory large cell lymphoma</a> and <a href=\"https://onlinelibrary.wiley.com/doi/10.1111/bjh.70018?af=R\" rel=\"noopener noreferrer\" target=\"_blank\">BSH good practice paper on the clinical management of bispecific antibody therapy for lymphoma</a>.</p>","author_name":"Richard Buka"}